Short Communication
Oncogene (2008) 27, 3746–3753; doi:10.1038/sj.onc.1211029; published online 28 January 2008
Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells
S H Hsieh1,6, N W Ying1,6, M H Wu2, W F Chiang3, C L Hsu4, T Y Wong1, Y T Jin1, T M Hong5,6 and Y L Chen1,2,6
- 1Institute of Oral Medicine, National Cheng Kung University, College of Medicine, Tainan, Taiwan
- 2Institute of Basic Medical Sciences, National Cheng Kung University, College of Medicine, Tainan, Taiwan
- 3Oral and Maxillofacial Section, Chi-Mei Medical Center, Tainan, Taiwan
- 4Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan
- 5The NTU Center for Genomic Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
Correspondence: Dr YL Chen, Institute of Oral Medicine, National Cheng Kung University, College of Medicine, 1 University Road, Tainan 70101, Taiwan. E-mail: yuhling@mail.ncku.edu.tw; Dr TM Hong, The NTU Center for Genomic Medicine, College of Medicine, National Taiwan University, 1, Sec1, Jen Ai Road, Taipei, Taiwan. E-mail: htm@gate.sinica.edu.tw
6These authors contributed equally to this work.
Received 13 September 2007; Revised 26 November 2007; Accepted 10 December 2007; Published online 28 January 2008.
Abstract
Galectin-1 (Gal-1), a homodimeric prototype of the galectins with a single carbohydrate-recognition domain, was recently identified as being overexpressed in tumor-associated capillary endothelial cells. The role of Gal-1 in endothelial cellular functions and the mechanism of action of Gal-1 remain unknown. Neuropilin-1 (NRP1) is a neuronal receptor that mediates repulsive growth cone guidance, and NRP1 functions in endothelial cells as a coreceptor (with vascular endothelial growth factor receptors (VEGFRs)) for VEGF165. In this study, we found that Gal-1 was overexpressed in the tumor-associated endothelial cells of oral squamous cell carcinomas (P<0.001). Gal-1 increased the proliferation and adhesion of endothelial cells, and enhanced cell migration in combination with VEGF165. Surprisingly, Gal-1 selectively bound NRP1 via the carbohydrate-recognition domain, but did not bind VEGFR-1, VEGFR-2 or VEGFR-3. The Gal-1–NRP1 interaction mediated the migration and adhesion of endothelial cells. The binding of Gal-1 to NRP1 enhanced VEGFR-2 phosphorylation and stimulated the activation of the mitogen activated protein (MAP) kinases SAPK1/JNK (stress activated protein kinase-1/c-Jun NH2-terminal kinase). These findings show, for the first time, that Gal-1 can directly bind to NRP1 on endothelial cells, and can promote the NRP1/VEGFR-2-mediated signaling pathway as well as NRP1-mediated biological activities.
Keywords:
galectin-1, neuropilin-1, endothelial cells, oral cancer
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Implications of vascular endothelial growth factor for postischemic neurovascular remodeling
Journal of Cerebral Blood Flow & Metabolism Review
RESEARCH
Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B
Oncogene Original Article
Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1
The EMBO Journal Article (07 Mar 2007)
Spheroid-based engineering of a human vasculature in mice
Nature Methods Article (01 May 2008)
Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling
The EMBO Journal Article (12 Jul 2006)
